261 related articles for article (PubMed ID: 29255418)
1. vNN Web Server for ADMET Predictions.
Schyman P; Liu R; Desai V; Wallqvist A
Front Pharmacol; 2017; 8():889. PubMed ID: 29255418
[TBL] [Abstract][Full Text] [Related]
2. ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries.
Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
Bioinformatics; 2024 Jun; ():. PubMed ID: 38913862
[TBL] [Abstract][Full Text] [Related]
3. ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries.
Swanson K; Walther P; Leitz J; Mukherjee S; Wu JC; Shivnaraine RV; Zou J
bioRxiv; 2023 Dec; ():. PubMed ID: 38234753
[TBL] [Abstract][Full Text] [Related]
4. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties.
Xiong G; Wu Z; Yi J; Fu L; Yang Z; Hsieh C; Yin M; Zeng X; Wu C; Lu A; Chen X; Hou T; Cao D
Nucleic Acids Res; 2021 Jul; 49(W1):W5-W14. PubMed ID: 33893803
[TBL] [Abstract][Full Text] [Related]
5. Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development.
Hsiao Y; Su BH; Tseng YJ
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32770190
[TBL] [Abstract][Full Text] [Related]
6. FP-ADMET: a compendium of fingerprint-based ADMET prediction models.
Venkatraman V
J Cheminform; 2021 Sep; 13(1):75. PubMed ID: 34583740
[TBL] [Abstract][Full Text] [Related]
7. ADMETboost: a web server for accurate ADMET prediction.
Tian H; Ketkar R; Tao P
J Mol Model; 2022 Dec; 28(12):408. PubMed ID: 36454321
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning for In Silico ADMET Prediction.
Jia L; Gao H
Methods Mol Biol; 2022; 2390():447-460. PubMed ID: 34731482
[TBL] [Abstract][Full Text] [Related]
9. ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping.
Yang H; Sun L; Wang Z; Li W; Liu G; Tang Y
J Chem Inf Model; 2018 Oct; 58(10):2051-2056. PubMed ID: 30251842
[TBL] [Abstract][Full Text] [Related]
10. Open access in silico tools to predict the ADMET profiling of drug candidates.
Kar S; Leszczynski J
Expert Opin Drug Discov; 2020 Dec; 15(12):1473-1487. PubMed ID: 32735147
[TBL] [Abstract][Full Text] [Related]
11. In silico ADMET prediction: recent advances, current challenges and future trends.
Cheng F; Li W; Liu G; Tang Y
Curr Top Med Chem; 2013; 13(11):1273-89. PubMed ID: 23675935
[TBL] [Abstract][Full Text] [Related]
12. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
[TBL] [Abstract][Full Text] [Related]
13. A model validation and consensus building environment.
Abshear T; Banik GM; D'Souza ML; Nedwed K; Peng C
SAR QSAR Environ Res; 2006 Jun; 17(3):311-21. PubMed ID: 16815770
[TBL] [Abstract][Full Text] [Related]
14. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
Khan MT; Sylte I
Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
[TBL] [Abstract][Full Text] [Related]
15. ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database.
Dong J; Wang NN; Yao ZJ; Zhang L; Cheng Y; Ouyang D; Lu AP; Cao DS
J Cheminform; 2018 Jun; 10(1):29. PubMed ID: 29943074
[TBL] [Abstract][Full Text] [Related]
16. Interpretable-ADMET: a web service for ADMET prediction and optimization based on deep neural representation.
Wei Y; Li S; Li Z; Wan Z; Lin J
Bioinformatics; 2022 May; 38(10):2863-2871. PubMed ID: 35561160
[TBL] [Abstract][Full Text] [Related]
17. ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd H; Gifford E
Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
[TBL] [Abstract][Full Text] [Related]
18. Recent uses of topological indices in the development of in silico ADMET models.
Votano JR
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
[TBL] [Abstract][Full Text] [Related]
19. In Silico Exploration of Aryl Halides Analogues as Checkpoint Kinase 1 Inhibitors by Using 3D QSAR, Molecular Docking Study, and ADMET Screening.
Ghaleb A; Aouidate A; Bouachrine M; Lakhlifi T; Sbai A
Adv Pharm Bull; 2019 Feb; 9(1):84-92. PubMed ID: 31011562
[No Abstract] [Full Text] [Related]
20. Development of in Silico Models for Predicting P-Glycoprotein Inhibitors Based on a Two-Step Approach for Feature Selection and Its Application to Chinese Herbal Medicine Screening.
Yang M; Chen J; Shi X; Xu L; Xi Z; You L; An R; Wang X
Mol Pharm; 2015 Oct; 12(10):3691-713. PubMed ID: 26376206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
